News

Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request
The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.
Rescued by fat bubbles: Scientists treat rare genetic disease with designer molecule
Tiny fat bubbles carrying gene therapy have successfully repaired DNA in the lungs and liver of animals with alpha-1 ...
GEN - Genetic Engineering and Biotechnology News14h
StockWatch: Sarepta Shares Nosedive after LGMD Gene Therapy Patient Dies
The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...
Gene Therapy Maker Sarepta Tells Fda It Won't Halt Shipments Despite Patient Deaths
Drugmaker Sarepta Therapeutics said late Friday it will not comply with a request from the Food and Drug Administration to ...
Hoodline5h
Sarepta Therapeutics Announces Layoff of 493 Employees, Including 80 in Ohio, Amid FDA Scrutiny and Stock Decline
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
Earth.com3h
Rethinking stevia: The sweet leaf that may fight cancer
Fermented stevia with banana leaf bacteria kills pancreatic cancer cells in lab tests. A compound called CAME triggers cell death.
The Brighterside of News on MSN8h
Natural sweetener Stevia found safe and effective at killing pancreatic cancer cells
Pancreatic cancer continues to pose one of the greatest challenges in global cancer treatment. Known for its aggressive nature and resistance to therapy, it carries a grim five-year survival rate of ...